Table 4.
KEGG pathway of DEmRNA in clear cell renal cell carcinoma
| ID | Term | Genes | Count | Corrected P‐value |
|---|---|---|---|---|
| hsa05200 | Pathways in cancer | COL4A4,VEGFA,SPI1,FASLG | 4 | .00405917615921 |
| hsa04060 | Cytokine‐cytokine receptor interaction | CCL20,VEGFA,FASLG | 3 | .0133388641347 |
| hsa04151 | PI3K‐Akt signaling pathway | VEGFA,COL4A4,FASLG | 3 | .005910498 |
| hsa04512 | ECM‐receptor interaction | COL4A4,CD36 | 2 | .009660452 |
| hsa05323 | Rheumatoid arthritis | CCL20,VEGFA | 2 | .015264 |
| hsa04933 | AGE‐RAGE signaling pathway in diabetic complications | COL4A4,VEGFA | 2 | .015566 |
| hsa04722 | Neurotrophin signaling pathway | NTRK2,FASLG | 2 | .018629 |
| hsa04062 | Chemokine signaling pathway | CCL20,ITK | 2 | .033286 |
| hsa04510 | Focal adhesion | COL4A4,VEGFA | 2 | .033286 |
| hsa05169 | Epstein‐Barr virus infection | SPI1,VIM | 2 | .033286 |
| hsa05205 | Proteoglycans in cancer | FASLG,VEGFA | 2 | .033286 |
| hsa04014 | Ras signaling pathway | FASLG,VEGFA | 2 | .0374 |
| hsa04010 | MAPK signaling pathway | FASLG,NTRK2 | 2 | .042737 |